Treatment beyond progression with immune checkpoint inhibitors in advanced melanoma.

Paweł Sobczuk,Anna M. Czarnecka,Mateusz Spałek,Paweł Teterycz,Monika Dudzisz-Śledź,Tomasz Świtaj,Paweł Rogala,Joanna Placzke,Katarzyna Kozak,Aneta Borkowska,Hanna Koseła-Paterczyk,Piotr Rutkowski

Treatment beyond progression with immune checkpoint inhibitors in advanced melanoma.

2021

Paweł Sobczuk
Anna M. Czarnecka
Mateusz Spałek
Paweł Teterycz
Monika Dudzisz-Śledź
Tomasz Świtaj
Paweł Rogala
Joanna Placzke
Katarzyna Kozak
Aneta Borkowska
Hanna Koseła-Paterczyk
Piotr Rutkowski

e21541Background: Immunotherapy (ITH) holds the possibility of tumor burden decrease after initial RECIST defined progression (PD). Clinical concept of treating of selected patients (pts) beyond PD...

Keywords:

Cancer research
Immunotherapy
advanced melanoma
Medicine
tumor burden
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations